OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Antibodies play a key role in the immune system and our response to vaccines, and have shown great promise as biotherapeutics. The development of new biotherapeutics typically takes many years and requires over $1bn in investment. Computational methods and in particular, machine learning, have shown great promise for increasing the speed and reducing the cost of biotherapeutic development.
In this talk I will describe some of the novel computational tools and databases we are pioneering in biotherapeutics from accurate rapid structure prediction to the prediction of their affinity and binding, looking at both their promise and limitations.
